Request for Covid-19 Impact Assessment of this Report

Diagnostic and Biotech

United States Glaucoma Therapeutics Devices Sales Market Report 2021

  • QYR635908
  • 122 Pages
  • August 2016
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
This report studies sales (consumption) of Glaucoma Therapeutics Devices in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Allergan Inc.

Merck & Co. Inc.

Novartis AG

Pfizer Inc.

Acadia Pharmaceuticals Inc.

AC Immune SA

Acorn Biomedical Inc.

Advanced Cell Technology Inc.

Aerie Pharmaceuticals Inc.

Carl Zeiss Meditec Inc.

Falcon Pharmaceuticals Ltd.

Inotek Pharmaceuticals Corp.

Lexicon Pharmaceuticals Inc.

Neurotech Pharmaceuticals Inc.

NicOx SA

Otsuka Holdings Co. Ltd.

Phytopharm plc

Santen Pharmaceuticals Co. Ltd.

Senju Pharmaceutical Co. Ltd.

SIFI SpA

Valeant Pharmaceuticals International Inc.

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Prostaglandins

Beta Blockers

Alpha Adrenergic Agonists

Carbonic Anhydrase Inhibitors

Fixed Dose Combinations

Split by applications, this report focuses on sales, market share and growth rate of Glaucoma Therapeutics Devices in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

United States Glaucoma Therapeutics Devices Sales Market Report 2021

1 Glaucoma Therapeutics Devices Overview

1.1 Product Overview and Scope of Glaucoma Therapeutics Devices

1.2 Classification of Glaucoma Therapeutics Devices

1.2.1 Prostaglandins

1.2.2 Beta Blockers

1.2.3 Alpha Adrenergic Agonists

1.2.4 Carbonic Anhydrase Inhibitors

1.2.5 Fixed Dose Combinations

1.3 Applications of Glaucoma Therapeutics Devices

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 USA Market Size (Value and Volume) of Glaucoma Therapeutics Devices (2011-2021)

1.4.1 USA Glaucoma Therapeutics Devices Sales, Revenue and Price (2011-2021)

1.4.2 USA Glaucoma Therapeutics Devices Sales and Growth Rate (2011-2021)

1.4.3 USA Glaucoma Therapeutics Devices Revenue and Growth Rate (2011-2021)

2 USA Glaucoma Therapeutics Devices Competition by Manufacturers

2.1 USA Glaucoma Therapeutics Devices Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Glaucoma Therapeutics Devices Revenue and Share by Manufactures (2015 and 2016)

3 USA Glaucoma Therapeutics Devices (Volume and Value) by Type

3.1 USA Glaucoma Therapeutics Devices Sales and Market Share by Type (2011-2021)

3.2 USA Glaucoma Therapeutics Devices Revenue and Market Share by Type (2011-2021)

4 USA Glaucoma Therapeutics Devices (Volume) by Application

5 USA Glaucoma Therapeutics Devices Manufacturers Analysis

5.1 Allergan Inc.

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Glaucoma Therapeutics Devices Product Type and Technology

5.1.2.1 Prostaglandins

5.1.2.2 Beta Blockers

5.1.3 Glaucoma Therapeutics Devices Sales, Revenue, Price of Allergan Inc. (2015 and 2016)

5.2 Merck & Co. Inc.

5.2.1 Company Basic Information,Manufacturing Base and Competitors

5.2.2 Medical Devices Product Type and Technology

5.2.2.1 Prostaglandins

5.2.2.2 Beta Blockers

5.2.3 Medical Devices Sales, Revenue, Price of Merck & Co. Inc. (2015 and 2016)

5.3 Novartis AG

5.3.1 Company Basic Information,Manufacturing Base and Competitors

5.3.2 Novartis AG Product Type and Technology

5.3.2.1 Prostaglandins

5.3.2.2 Beta Blockers

5.3.3 Novartis AG Sales, Revenue, Price of Novartis AG (2015 and 2016)

5.4 Pfizer Inc.

5.4.1 Company Basic Information,Manufacturing Base and Competitors

5.4.2 Aerie Pharmaceuticals Inc. Product Type and Technology

5.4.2.1 Prostaglandins

5.4.2.2 Beta Blockers

5.4.3 Pfizer Inc. Sales, Revenue, Price of Pfizer Inc. (2015 and 2016)

5.5 Acadia Pharmaceuticals Inc.

5.5.1 Company Basic Information,Manufacturing Base and Competitors

5.5.2 Acadia Pharmaceuticals Inc. Product Type and Technology

5.5.2.1 Prostaglandins

5.5.2.2 Beta Blockers

5.5.3 Acadia Pharmaceuticals Inc. Sales, Revenue, Price of Acadia Pharmaceuticals Inc. (2015 and 2016)

5.6 AC Immune SA

5.6.1 Company Basic Information,Manufacturing Base and Competitors

5.6.2 AC Immune SA Product Type and Technology

5.6.2.1 Prostaglandins

5.6.2.2 Beta Blockers

5.6.3 AC Immune SA Sales, Revenue, Price of AC Immune SA (2015 and 2016)

5.7 Acorn Biomedical Inc.

5.7.1 Company Basic Information,Manufacturing Base and Competitors

5.7.2 Acorn Biomedical Inc. Product Type and Technology

5.7.2.1 Prostaglandins

5.7.2.2 Beta Blockers

5.7.3 Acorn Biomedical Inc. Sales, Revenue, Price of Acorn Biomedical Inc. (2015 and 2016)

5.8 Advanced Cell Technology Inc.

5.8.1 Company Basic Information,Manufacturing Base and Competitors

5.8.2 Advanced Cell Technology Inc. Product Type and Technology

5.8.2.1 Prostaglandins

5.8.2.2 Beta Blockers

5.8.3 Advanced Cell Technology Inc. Sales, Revenue, Price of Advanced Cell Technology Inc. (2015 and 2016)

5.9 Aerie Pharmaceuticals Inc.

5.9.1 Company Basic Information,Manufacturing Base and Competitors

5.9.2 Aerie Pharmaceuticals Inc. Product Type and Technology

5.9.2.1 Prostaglandins

5.9.2.2 Beta Blockers

5.9.3 Aerie Pharmaceuticals Inc. Sales, Revenue, Price of Aerie Pharmaceuticals Inc. (2015 and 2016)

5.10 Carl Zeiss Meditec Inc.

5.10.1 Company Basic Information,Manufacturing Base and Competitors

5.10.2 Carl Zeiss Meditec Inc. Product Type and Technology

5.10.2.1 Prostaglandins

5.10.2.2 Beta Blockers

5.10.3 Carl Zeiss Meditec Inc. Sales, Revenue, Price of Carl Zeiss Meditec Inc. (2015 and 2016)

5.11 Falcon Pharmaceuticals Ltd.

5.12 Inotek Pharmaceuticals Corp.

5.13 Lexicon Pharmaceuticals Inc.

5.14 Neurotech Pharmaceuticals Inc.

5.15 NicOx SA

5.16 Otsuka Holdings Co. Ltd.

5.17 Phytopharm plc

5.18 Santen Pharmaceuticals Co. Ltd.

5.19 Senju Pharmaceutical Co. Ltd.

5.20 SIFI SpA

5.21 Valeant Pharmaceuticals International Inc.

6 Glaucoma Therapeutics Devices Technology and Development Trend

6.1 Glaucoma Therapeutics Devices Technology Analysis

6.2 Glaucoma Therapeutics Devices Technology Development Trend

7 Research Findings and Conclusion

List Of Tables and Figures

Figure Picture of Glaucoma Therapeutics Devices

Table Classification of Glaucoma Therapeutics Devices

Figure USA Sales Market Share of Glaucoma Therapeutics Devices by Type in 2015

Figure Prostaglandins Picture

Figure Beta Blockers Picture

Figure Alpha Adrenergic Agonists Picture

Figure Carbonic Anhydrase Inhibitors Picture

Figure Fixed Dose Combinations Picture

Table Applications of Glaucoma Therapeutics Devices

Figure USA Sales Market Share of Glaucoma Therapeutics Devices by Application in 2015

Table USA Glaucoma Therapeutics Devices Sales, Revenue and Price (2011-2021)

Figure USA Glaucoma Therapeutics Devices Sales and Growth Rate (2011-2021)

Figure USA Glaucoma Therapeutics Devices Revenue and Growth Rate (2011-2021)

Table USA Glaucoma Therapeutics Devices Sales of Key Manufacturers (2015 and 2016)

Table USA Glaucoma Therapeutics Devices Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Glaucoma Therapeutics Devices Sales Share by Manufacturers

Figure 2016 Glaucoma Therapeutics Devices Sales Share by Manufacturers

Table USA Glaucoma Therapeutics Devices Revenue by Manufacturers (2015 and 2016)

Table USA Glaucoma Therapeutics Devices Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA Glaucoma Therapeutics Devices Revenue Share by Manufacturers

Table 2016 USA Glaucoma Therapeutics Devices Revenue Share by Manufacturers

Table USA Glaucoma Therapeutics Devices Sales and Market Share by Type (2011-2021)

Table USA Glaucoma Therapeutics Devices Sales Share by Type (2011-2021)

Figure Sales Market Share of Glaucoma Therapeutics Devices by Type (2011-2021)

Figure USA Glaucoma Therapeutics Devices Sales Growth Rate by Type (2011-2021)

Table USA Glaucoma Therapeutics Devices Revenue and Market Share by Type (2011-2021)

Table USA Glaucoma Therapeutics Devices Revenue Share by Type (2011-2021)

Figure Revenue Market Share of Glaucoma Therapeutics Devices by Type (2011-2021)

Figure USA Glaucoma Therapeutics Devices Revenue Growth Rate by Type (2011-2021)

Table USA Glaucoma Therapeutics Devices Sales and Market Share by Application (2011-2021)

Table USA Glaucoma Therapeutics Devices Sales Share by Application (2011-2021)

Figure Sales Market Share of Glaucoma Therapeutics Devices by Application (2011-2021)

Figure USA Glaucoma Therapeutics Devices Sales Growth Rate by Application (2011-2021)

Table Allergan Inc. Basic Information List

Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Allergan Inc. (2015 and 2016)

Table Merck & Co. Inc. Basic Information List

Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Merck & Co. Inc. (2015 and 2016)

Table Novartis AG Basic Information List

Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Novartis AG (2015 and 2016)

Table Pfizer Inc. Basic Information List

Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Pfizer Inc. (2015 and 2016)

Table Acadia Pharmaceuticals Inc. Basic Information List

Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Acadia Pharmaceuticals Inc. (2015 and 2016)

Table AC Immune SA Basic Information List

Table Glaucoma Therapeutics Devices Sales, Revenue, Price of AC Immune SA (2015 and 2016)

Table Acorn Biomedical Inc. Basic Information List

Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Acorn Biomedical Inc. (2015 and 2016)

Table Advanced Cell Technology Inc. Basic Information List

Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Advanced Cell Technology Inc. (2015 and 2016)

Table Aerie Pharmaceuticals Inc. Basic Information List

Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Aerie Pharmaceuticals Inc. (2015 and 2016)

Table Carl Zeiss Meditec Inc. Basic Information List

Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Carl Zeiss Meditec Inc. (2015 and 2016)

Table Falcon Pharmaceuticals Ltd. Basic Information List

Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Falcon Pharmaceuticals Ltd. (2015 and 2016)

Table Inotek Pharmaceuticals Corp. Basic Information List

Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Inotek Pharmaceuticals Corp. (2015 and 2016)

Table Lexicon Pharmaceuticals Inc. Basic Information List

Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Lexicon Pharmaceuticals Inc. (2015 and 2016)

Table Neurotech Pharmaceuticals Inc. Basic Information List

Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Neurotech Pharmaceuticals Inc. (2015 and 2016)

Table NicOx SA Basic Information List

Table Glaucoma Therapeutics Devices Sales, Revenue, Price of NicOx SA (2015 and 2016)

Table Otsuka Holdings Co. Ltd. Basic Information List

Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Otsuka Holdings Co. Ltd. (2015 and 2016)

Table Phytopharm plc Basic Information List

Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Phytopharm plc (2015 and 2016)

Table Santen Pharmaceuticals Co. Ltd. Basic Information List

Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Santen Pharmaceuticals Co. Ltd. (2015 and 2016)

Table Senju Pharmaceutical Co. Ltd. Basic Information List

Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Senju Pharmaceutical Co. Ltd. (2015 and 2016)

Table SIFI SpA Basic Information List

Table Glaucoma Therapeutics Devices Sales, Revenue, Price of SIFI SpA (2015 and 2016)

Table Valeant Pharmaceuticals International Inc. Basic Information List

Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Valeant Pharmaceuticals International Inc. (2015 and 2016)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Biomaterials Market by Type (Metallic, Polymeric, Ceramic and Natural) and Application (Cardiovascular, Dental, Orthopedic, Wound Healing, Plastic, Surgery, Ophthalmology, Tissue Engineering, Neurological Disorders and Drug-Delivery Systems) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...

  • Publish Date: September 1, 2016
  • $5370
DNA Sequencing Market by Product (Consumable, Instrument, and Service) Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2017 - 2025

The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...

  • Publish Date: May 24, 2017
  • $5370